Dag Berild - Infectious Diseases

Author Information

Dag Berild is a researcher affiliated with the Department of Infectious Diseases at Oslo University Hospital and the Faculty of Medicine at the University of Oslo, located in Norway. His work primarily focuses on infectious diseases, with a particular interest in antibiotic use and resistance. His affiliation with a leading medical institution underscores his active role in advancing medical research and contributing to the field of infectious diseases.

Research Contributions

Dag Berild has made significant contributions to the field of infectious diseases, particularly in understanding and optimizing antibiotic use. His research includes studies on antimicrobial exposure in infants, antibiotic stewardship, and resistance patterns. Notable works include investigations into the factors affecting antibiotic prescriptions, antimicrobial resistance in Nordic hospitals, and the implications of procalcitonin use for antimicrobial stewardship. His research aims to improve antibiotic use practices and reduce resistance, focusing on vulnerable populations such as neonates and hospitalized children.

Aliases

Dag Berild is also known by the aliases D Berild and D. Berild, which are used interchangeably in his publications and academic contributions.

Publication and Citation Metrics

Metric	Value
Total Papers	109
Total Citation Count	1113
H-index	20

Publications:

Are infants exposed to antimicrobials during the first 3 months of life at increased risk of recurrent use? An explorative data-linkage study.

DOI: 10.1093/jac/dkac024

Year: 2022

Corrigendum: Can We Optimize Antibiotic Use in Norwegian Neonates? A Prospective Comparison Between a University Hospital and a District Hospital

DOI: 10.3389/fped.2022.862484

Year: 2022

Factors Affecting Antibiotic Prescription among Hospital Physicians in a Low-Antimicrobial-Resistance Country: A Qualitative Study

DOI: 10.3390/antibiotics11010098

Year: 2022

Antibiotic Use in Children Before, During and After Hospitalization.

DOI: 10.1002/pds.5438

Year: 2022

Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018

DOI: 10.1080/23744235.2021.1910338

Year: 2021

Gastrointestinal symptoms in invasive pneumococcal disease: a cohort study

DOI: 10.1186/s12879-020-05211-3

Year: 2020

Antibiotic stewardship in premature infants: a systematic review

DOI: 10.1101/2020.04.10.20060988

Year: 2020

Antibiotic Stewardship in Premature Infants: A Systematic Review.

DOI: 10.1159/000511710

Year: 2020

Hospital physicians’ experiences with procalcitonin – implications for antimicrobial stewardship; a qualitative study

DOI: 10.1186/s12879-020-05246-6

Year: 2020

Poor antimicrobial therapy, commendable candour.

DOI: 10.4045/tidsskr.20.0711

Year: 2020

What is Vector Borne Transmission?

How Can We Combat Antibiotic Resistance?

How is E. Coli Diagnosed?

What are the Symptoms of Strep Throat?

How can public health responses be improved?

How does ELISA work?

What Are the Risks to the Fetus?

What are Vaccines?

How Can We Improve Global Health Infrastructure to Combat Infectious Diseases?

How Does Vaccine Hesitancy Impact Public Health?

Partnered Content Networks

Relevant Topics